Dr Ricky Frazer and Dr Anna Olsson-Brown
The Immunobuddies
Buddies with an interest in the area of immunotherapy and its development. We simply discuss the dilemmas, challenges and progress made in the management of patients receiving immunotherapies to treat cancer.
Author
Dr Ricky Frazer and Dr Anna Olsson-Brown
Category
Podcast website
Latest episode
Jul 10, 2026
Where to listen?
Podcasts in the app Replaio Radio Coming soonPodcasts are coming to the app soon. Install now and be the first to see a whole new take on podcasts
Install for free
Android 5M+ downloads · 4.8 rating
iOS soon
Episodes
Episode 86: Oncolytic Viruses Demystified - is the Future bright? with Professor Kevin Harrington 17.05.2024 17:14
Send us Fan Mail
Episode 85: Oncolytic Viruses Demystified - Real Life Clinical Application with Professor Kevin Harrington 10.05.2024 18:45
Send us Fan Mail
Episode 84: Oncolytic Viruses Demystified - A Simplified Overview with Professor Kevin Harrington 03.05.2024 22:06
Send us Fan Mail
Episode 83: IO and radiotherapy Final Part Practical Application with Professor Kevin Harrington 26.04.2024 27:41
Send us Fan Mail
Episode 82: Part 2 - The role of Radiotherapy in enhancing the immune response with Professor Kevin Harrington 19.04.2024 18:41
Send us Fan Mail
Episode 81: Abscopal effect, real or imagined? The role of Radiotherapy in enhancing the immune response with Professor Kevin Harrington 12.04.2024 27:33
Send us Fan Mail
Episode 80: Immunology Final Part with Professor Mark Coles - The Future 05.04.2024 25:53
Send us Fan Mail
Episode 79 Immunology Part 2 Clinical Application with Professor Mark Coles 29.03.2024 22:45
Send us Fan Mail
Episode 78: Overview of Immunology (Getting to grips with the basic science that underpins immunotherapy) with Professor Mark Coles 22.03.2024 33:27
Send us Fan Mail
Episode 77: Fatigue - Chronic Causes and Fatigue Bundle 15.03.2024 15:56
Send us Fan Mail
Episode 76: Fatigue - Subacute Causes 08.03.2024 29:02
Send us Fan Mail
Episode 75: Fatigue - Acute Causes 01.03.2024 38:19
Send us Fan Mail
Episode 74: Fatigue - Definition and Approach 23.02.2024 18:22
Send us Fan Mail
Episode 73: REFINE Trial with Dr Sophie Merrick and how to get involved - https://refine.mrcctu.ucl.ac.uk/ 16.02.2024 20:32
Send us Fan Mail
Episode 72: Dose, Frequency and Duration of Immunotherapy Part 2 with Cancer Research UK Clinical Fellow Dr Sophie Merrick 09.02.2024 30:03
Send us Fan Mail
Episode 71: Dose, Frequency and Duration of Immunotherapy with Cancer Research UK Clinical Fellow Dr Sophie Merrick 02.02.2024 31:43
Send us Fan Mail
Episode 70: What is next for the Microbiome? Future Practical Implications for Patient Care - FMT and Beyond with Melanoma Institute Australia and The University of Sydney - Dr Rebecca C Simpson and Dr Erin R Shanahan 26.01.2024 18:48
Send us Fan Mail
Episode 69: The Practical Implications of the Microbiome for Patient Care with Melanoma Institute Australia and University of Sydney - Dr Rebecca C Simpson and Dr Erin R Shanahan 19.01.2024 21:10
Send us Fan Mail
Episode 68: The Microbiome with Melanoma Institute Australia and University of Sydney - Dr Rebecca C Simpson and Dr Erin R Shanahan 12.01.2024 29:46
Send us Fan Mail
Episode 67: Cancer Vaccines with Professor Lennard Lee - A silver lining of the pandemic 05.01.2024 34:56
Send us Fan Mail
Episode 66: Influence of Genome and Cytokines (IL7) on Immunotherapy Toxicity with Dr Robert Watson 29.12.2023 33:15
Send us Fan Mail
Episode 65: Dermatological (Skin Toxicities) Complex and Tricky Toxicities Final Part 22.12.2023 33:42
Send us Fan Mail
Episode 64: Dermatological (Skin Toxicities) Complex and Tricky Toxicities 15.12.2023 21:16
Send us Fan Mail
Episode 63: Dermatological (Skin Toxicities) Severe 08.12.2023 38:06
Send us Fan Mail
Episode 62: Dermatological (Skin Toxicities) - Overview 01.12.2023 33:41
Send us Fan Mail
Similar podcasts
Listen to the The Immunobuddies podcast in Replaio
Radio and podcasts in one app - free, with no sign-up. Install today and do not miss the launch
Replaio is not a podcast publisher; show names, artwork and audio belong to their authors and are distributed through public RSS feeds.
